slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 93,031-93,060
Pages 3,953
Rows per page 30
Component
93,031-93,060 of 118,578
01
Features a stylized brain-circuitry graphic.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
06
The slide combines a bar chart for revenue projections and a segmented pie/fan chart for patient population sizing.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
08
The slide uses a list-based framework to justify the clinical development path.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
09
The slide uses a split-layout: left side lists clinical symptoms/causes, right side details functional impact on life domains.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
10
The slide uses a combination of a bar chart for revenue projections and a layered pie/segmentation graphic for patient population sizing.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
11
The slide uses a central head-shaped graphic to frame the core thesis, with supporting evidence listed to the right.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Why Now1 hit
14
Figures as of March 30, 2022.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
16
Bionomics | Investor Presentation Deck | 16 slidesBionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations 1 hit
01
The year '2022' is stylized with biological imagery inside the digits.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
03
This is a standard pharmaceutical regulatory disclosure slide.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
12
Uses a horizontal progression layout to represent strategic evolution.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Solution OverviewLoop · Logic Chain1 hit
28
The slide uses a hub-and-spoke diagram centered on the BioNTech logo to illustrate the diversity of their technology platforms.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
29
The slide uses a modular diagram to show how different mRNA types (uRNA, modRNA, saRNA, taRNA) are combined with delivery vehicles (LPX, LNP, Polyplexes) to target specific areas of the body.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
42
The ROC curve shows the new model (blue) consistently outperforming the baseline NetMHCpan 4.1 EL (orange).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
50
The slide uses two timeline-style metrics to show growth in clinical batch capacity and bulk mRNA batch size.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
61
The slide uses a three-column layout to present the problem, with a footer section listing the company's solutions.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
65
The slide uses a before-after framing to contrast efficacy and safety data.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
66
The slide uses a timeline-like progression of vaccine development stages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
94
The slide uses a process-flow style to show how different modalities combine to produce specific clinical outcomes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
107
The slide illustrates the modular nature of the FixVac platform, showing how different antigen cassettes are used for specific cancers (Melanoma, HPV16+ HNSCC, Prostate cancer, NSCLC).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
108
The slide uses a combination of metrics and a callout box to frame the clinical problem.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
112
The slide uses a swimmer plot to visualize disease-free survival and stacked bar charts for T-cell response rates.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
120
Includes clinical trial data for BNT311; displays best change from baseline and longitudinal change over study weeks.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
01
Canada Goose | Investor Presentation Deck | 24 slidesCanada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
02
Canada Goose | Investor Presentation Deck | 24 slidesCanada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations 1 hit
04
This is a cover-style transition slide for the company history section.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Problem1 hit